Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Cancer, Second Primary

cabergoline has been researched along with Cancer, Second Primary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coiré, CI; Horvath, E; Kovacs, K; Rosso, D; Smyth, HS1
Grotas, AB; Nagler, HM1

Other Studies

2 other study(ies) available for cabergoline and Cancer, Second Primary

ArticleYear
A double pituitary adenoma presenting as a prolactin-secreting tumor with partial response to medical therapy. Case report.
    Endocrine pathology, 2010, Volume: 21, Issue:2

    Topics: Adenoma; Adult; Antineoplastic Agents; Breast Neoplasms, Male; Cabergoline; Combined Modality Therapy; Ergolines; Gonadotrophs; Humans; Male; Microscopy, Electron, Transmission; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Neurofibromatosis 1; Neurosurgical Procedures; Prolactinoma

2010
Presentation of a functional pituitary adenoma as a significant decrease in prostate-specific antigen level in a patient followed for prostate cancer.
    The Canadian journal of urology, 2006, Volume: 13, Issue:6

    Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents; Cabergoline; Ergolines; Humans; Male; Neoplasms, Second Primary; Pituitary Neoplasms; Prolactinoma; Prostate-Specific Antigen; Prostatic Neoplasms

2006